ClinicalTrials.gg
Not yet recruitingNCT06895707Updated Mar 30, 2025

Clinical Evaluation of BioFlx Crowns and Preformed Zirconia Crowns on Primary Second Molars

An interventional study of BioFlx crown and Zirconia crown in Clincal Evaluation of BioFlx Vs. Zirconia Crowns, sponsored by Riyadh Elm University. Not yet recruiting. Open to participants aged 5 Years to 9 Years. Per ClinicalTrials.gov, last updated 2025-03-30.

Sponsored by Riyadh Elm University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Nov 2025, 1 year ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
5 Years to 9 Years
Sex
All
01

Study summary

The goal of this clinical trial is to clinically evaluate the performance of BioFlx in comparison to preformed zirconia crowns in the restoration of primary second molars in pediatric patients.

The main questions it aims to answer are:

Is there a difference between BioFlx crowns (Group A) and one zirconia (Group B) in terms of crown retention (primary outcome)? Is there a difference between BioFlx crowns (Group A) and one zirconia (Group B) in modified gingival index, plaque index, occlusion, surface roughness, stain resistance, wear of opposing tooth, color match, anatomic form, marginal integrity and discoloration, proximal contact, and recurrent caries at the crown margins?

Researchers will compare the clinical performance of Bioflx crowns and zirconia crowns to determine if they are similar.

Participants:

  • Participants will be asked to attend two appointments. During the first visit, a BioFlx crown will be placed on the primary lower second molar, and during the second visit, a zirconia crown will be placed on the contralateral primary lower second molar.
  • Participants will be recalled and evaluated after 3, 6, and 12 months.
02

Conditions studied

  • Clincal Evaluation of BioFlx Vs. Zirconia Crowns
03

In context

Lead sponsor

Riyadh Elm University is the lead sponsor of 26 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 9 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children aged 5-9 years old.
  • Classification I or II status.
  • Cooperative child.
  • Obtained .
  • Two primary lower second molars requiring full coverage restorations.
  • Primary lower second molars in functional occlusion with the opposing tooth and have at least one contact area with an adjacent tooth.
  • Primary lower second molars that can be adequately isolated.
  • Pulptomized primary lower second molars.
  • Primary lower second molars with multi-surface caries.

Exclusion criteria

Exclusion Criteria:

  • Classification higher or equal to three statuses.
  • is not obtained.
  • Allergy to local anesthesia.
  • Non-restorable primary lower second molars.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Primary lower second molar

    one NuSmile® BioFlx crown will be placed on primary lower second molar.

    Other: BioFlx crown

  • Active comparator
    Contralateral primary lower second molar

    one zirconia crown will be placed on the contralateral primary lower second molar.

    Other: Zirconia crown

Interventions

  • OtherBioFlx crown

    NuSmile® BioFlx crown (Group A) will be placed on primary lower second molar.

  • OtherZirconia crown

    Zirconia crown (Group B) will be placed on the contralateral primary lower second molar.

06

What researchers measure

Primary outcomes

  1. Crown retention

    Evaluate whether the crown is present or absent 0= present 1= absent

    Time frame: 3, 6, 12 months

Secondary outcomes

  1. Modified gingival index

    0= normal 1. mild inflammation 2. moderate inflammation 3. sever inflammation

    Time frame: 3, 6, 12 months

  2. Plaque index

    Plaque index 0= no plaque 1. film at gingival margin 2. moderate accumulation 3. abundance of plaque

    Time frame: 3, 6, 12 months

  3. Occlusion

    0= clinically ideal with crown in harmony with occlusion 1. clinically acceptable with crown occluding slightly high or low 2. clinically unacceptable and crown needs to be replaced

    Time frame: 3, 6, 12 months

  4. Surface roughness

    0= clinically ideal with smooth crown surface 1. clinically acceptable with slight rough surface 2. clinically unacceptable with crown fracture or pitting that require replacement

    Time frame: 3, 6, 12 months

  5. Stain resistance

    0= no staining 1. minor staining that can be polished 2. noticeable staining that cannot be polished

    Time frame: 3, 6, 12 months

  6. Wear of opposing tooth

    0= no wear 1. mild wear 2. severe wear

    Time frame: 3, 6, 12 months

  7. Color match

    0= no color mismatch 1. acceptable crown with color mismatch 2. unacceptable crown with color mismatch

    Time frame: 3, 6, 12 months

  8. Anatomic form

    0= clinically ideal 1. clinically acceptable (slightly under/over contoured) 2. clinically unacceptable (crown is missing or causing pain)

    Time frame: 3, 6, 12 months

  9. Marginal integrity and discoloration

    0= clinically ideal 1. clinically acceptable with slight discoloration 2. clinically unacceptable with clear discoloration

    Time frame: 3, 6, 12 months

  10. Proximal contact

    0= clinically ideal with acceptable resistance to the passage of floss 1. clinically acceptable with tight or loose passage of floss 2. clinically unacceptable with no contact with adjacent tooth

    Time frame: 3, 6, 12 months

  11. Recurrent caries

    0= clinically ideal with no presence of recurrent caries 1= clinically unacceptable with evidence of recurrent caries

    Time frame: 3, 6, 12 months

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for May 2025; primary completion for Nov 2025, 6 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 19, 2025
First posted
Mar 26, 2025
StartEst.
May 2025
Primary completionEst.
Nov 2025
CompletionEst.
Nov 2027
Last update
Mar 30, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06895707
Lead sponsor
Riyadh Elm University
Responsible party
Fatimah alsuwaiyan (Resident, Riyadh Elm University) — Principal investigator
First posted
Mar 26, 2025
Start date
May 2025 (estimated)
Primary completion
Nov 2025 (estimated)
Completion
Nov 2027 (estimated)
Last update
Mar 30, 2025

Study contacts

Fatimah A Alsuwaiyan, BDS
Contact
fatimah.a.alsuwaiyan2022@student.riyadh.edu.sa
001966508322281

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion